Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Treatment of Sickle Cell Anemia With Stem Cell Transplant
- Status
- TERMINATED
- Phase
- NA
Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
- Status
- UNKNOWN
- Phase
- NA
Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
- Status
- COMPLETED
- Phase
- PHASE3
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Research Study of ATG and Rituximab in Renal Transplantation
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE3
Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
- Status
- COMPLETED
- Phase
- PHASE3
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
- Status
- TERMINATED
- Phase
- PHASE3